Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States
收藏DataCite Commons2026-01-12 更新2026-05-03 收录
下载链接：
https://www.datalumos.org/datalumos/project/243577/view
下载链接
链接失效反馈官方服务：
资源简介：
Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction
• Estimated nirsevimab coverage for children 0-19 months is assessed through U.S. jurisdictions’ Immunization Information Systems (IIS) data, submitted from jurisdictions to CDC monthly in aggregate by age group.
• Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. (https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html)
Read less
提供机构：
ICPSR - Interuniversity Consortium for Political and Social Research
创建时间：
2026-01-12
